Metabolites in Safety Testing (MIST): Analytical Strategy

In this webinar, Dr. Philip Tiller reviews Metabolites in Safety Testing (MIST) and discusses the scientific foundation of our analytical approach. Finally Dr. Tiller shares a case study of our success.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

First Name*

Last Name*

Company*

State*

Country

Email*

Phone*

Please only hit the submit button once.

I AGREE*

By submitting this form I agree that Frontage may process my data in the manner described in Frontage’s Privacy Policy.

Metabolites in Safety Testing (MIST): Analytical Strategy

Resources to Consider

Biologics Analytical Testing Services

GMP Analytical Testing in Gene Therapy Products

Outsourcing Analytical Testing For Biologics – A CRO’s...

CMC GMP Analytical Testing for New Chemical Entities and Commercial...

CMC GMP Analytical Testing for Biologics

Cell-Free DNA NGS Testing

Testing of Carryover & After MRD Benchtop Stability for...

Guidelines for Developmental and Reproductive Toxicity (DART) Testing

Tissue IHC: from R&D to Clinical Lab Testing

Microbiological Testing Considerations for Pharmaceutical Products

Stability Testing

Intraperitoneal Dose Administration: Successful Testing Using IP...